Nature 533 (11 May 2016). Open Innovation. A transparent approach to biomedicine.
(*) This Nature Outlook was sponsored by Boehringer Ingelheim
Secrecy within the world of drug discovery and development is no longer as important as it once was. As development of therapies has become more difficult and costly, academics and industry competitors have begun to engage in greater collaboration and to embrace openness to accelerate research.
ACCESS ✎
Restricted
LANGUAGE ✎
English